Immunoglobulin G (IgG) is the most abundant serum antibody and is a key determinant of 47
the humoral immune response. Its structural characteristics and effector functions are 48 modulated through the attachment of various sugar moieties called glycans. IgG N-glycome 49 patterns change with the age of individual and in different diseases. Variability of IgG 50 glycosylation within a population is well studied and is affected by a combination of genetic 51 and environmental factors. However, global inter-population differences in IgG glycosylation 52 have never been properly addressed. Here we present population-specific N-glycosylation 53 patterns of whole IgG, analysed in 5 different populations totalling 10,482 IgG glycomes, and 54 of IgG's fragment crystallisable region (Fc), analysed in 2,530 samples from 27 populations 55 sampled across the world. We observed that country of residence associates with many N-56 glycan features and is a strong predictor of monogalactosylation variability. IgG 57 galactosylation also strongly correlated with the development level of a country, defined by 58
United Nations health and socioeconomic development indicators. We found that subjects 59 from developing countries had low IgG galactosylation levels, characteristic for inflammation 60
Introduction 64
Immunoglobulin G is the most abundant glycoprotein and antibody class in human plasma 1 . 65 It mediates interactions between antigens and the immune system 2 . There are four IgG 66 subclasses present in plasma: IgG1, IgG2, IgG3 and IgG4 3 . Each subclass has distinctive 67 functions, such as pronounced affinity for certain types of antigens, formation of immune 68 complexes, complement activation, interactions with effector cells, half-life and placental 69 transport 2 . 70
Glycosylation is co-and post-translational modification which is orchestrated by a complex 71 biosynthetic pathway 4 . IgG contains a conserved N-glycosylation site on Asn297 residue 72 within its fragment crystallisable (Fc) region on each of the two heavy chains 5 . Glycans 73 attached to IgG are a complex biantennary type, with core structure consisting of four N-74 acetylglucosamines and three mannoses. Different glycan moieties such as bisecting GlcNAc, 75 galactose, sialic acid and fucose can be attached to this core 6 . IgG shows a high degree of 76 glycosylation diversity. Each of four IgG subclasses displays a distinctive glycan profile 7 . 77 Also, each of the heavy chains of the same molecule can carry different glycans, creating a 78 large repertoire of possible glycan patterns 8 . Finally, in 15-20% of cases, an additional N-79 glycosylation site appears within a variable region of the antibody, as a result of sequence 80 variation in the variable region 9 . 81
The majority of IgG functions are achieved through interactions with receptors on immune 82 cells and complement proteins. Fc glycans affect immunoglobulin conformation, which, in 83 turn, defines binding affinity for Fc gamma receptors (FcγRs) on effector cells and 84 complement, leading to alternations in effector functions 1, 10 . IgG galactosylation has an 85 extensive effect on its inflammatory potential 11 . Namely, agalactosylated IgG increases 86 inflammation through activation of complement system 12,13 . Moreover, galactosylation was 87 found necessary for C1q complement component binding and activation of complement-88 dependent cytotoxicity (CDC) 14 . It was also required for increased binding of IgG to 89 activating Fc gamma receptors and therefore activation of antibody-dependent cellular 90 cytotoxicity (ADCC) 15 Prominent changes in the IgG glycome were found in a number of diseases. In different 104 autoimmune and alloimmune disorders, cancers and infectious diseases, IgG glycosylation 105 changes reflect the increase inflammation, which is accompanying these conditions 11 . The 106 impact of IgG glycosylation on its ability to modulate inflammation has been extensively 107 studied as a potential biomarker for disease prognosis and therapy response, as well as for 108 monoclonal antibody development 24, 25 . 109
Ageing is a process of damage aggregation in an organism, leading to the disruption of 110 health. It is influenced by both genetic factors and environment/lifestyle. In a healthy 111 individual, a gender-specific gradual change in IgG glycosylation can be observed with an increase of chronological age. Namely, digalactosylated structures decrease with age, while 113 agalactosylation and bisecting GlcNAc increase in older individuals 23 . On the other hand, 114 changes in sialylation and core fucosylation displayed inconsistent trends in different 115 studies 23 . Proposed model to describe and explain age-related changes in glycosylation is "the 116 inflammageing model", which implicates that inflammation causes changes in IgG 117 glycosylation which, in turn, accelerate the process of ageing 26 . Consequently, changing 118 under influence of both genes and environment, IgG glycans predict biological age and 119 represent a measure of organisms health 11 . 120
Despite the fact that structural and functional aspects of IgG glycosylation are intensively 121 studies and associated with predisposition and course of different diseases, little is known 122 about the regulation of IgG glycosylation or mechanisms that lead to extensive changes in 123 glycome composition after environmental challenge 11,27,28 . Therefore, the aim of this study 124 was to estimate and compare various IgG N-glycosylation patterns in populations across the 125 world as a result of their different genetic backgrounds and specific environmental 126 influences.
Results 128
Total IgG glycans change with chronological age 129
In the initial analysis, samples originating from 10,482 healthy individuals and 5 different 130 populations were analysed. Fluorescently labelled N-glycans released from IgG were 131 separated into 24 chromatographic peaks ( Supplementary Table 1 ; Supplementary Figure 1 ). 132
Additionally, derived glycan traits (galactosylation, core fucosylation, sialylation and 133 presence of bisecting GlcNAc) were calculated, based on the initial 24 glycan measures. 134
Derived glycan traits represent a portion of structurally similar glycan species in the total IgG 135 glycome ( Supplementary Table 2 ). In general, galactosylation showed the highest variability 136 of all IgG glycan traits, which is in line with the previous studies (Supplementary Figure 2) . 137
It is known that the chronological age of subject affects IgG glycosylation 23 . Age-related 138 changes were observed in the levels of IgG glycan traits in all studied populations ( Figure  139 1a). Agalactosylated species and glycans containing bisecting N-acetylglucosamine 140 (GlcNAc) increased with the chronological age of the participant. The opposite trend was 141 observed for the levels of digalactosylated and sialylated glycans, which were decreasing 142 with chronological age. On the other hand, core fucosylation and monogalactosylation levels 143 did not change consistently with age. Also, age-related changes in glycosylation displayed 144 sex-specific patterns, where female participants displayed more rapid changes. 145
Age and country of residence can predict total IgG glycosylation 146
Although total IgG N-glycans showed similar age-related changes within each of the studied 147 cohorts, every population displayed particular glycan patterns ( Figure 1b ). Again, the most 148 pronounced differences between populations were observed in the levels of agalactosylated 149 glycans, which increased with a median age of the analysed population. This glycan trait had 150 the lowest median value in young Chinese cohort (20%), while the highest was observed in 151 Estonian cohort (36%), which contained the oldest population. Besides agalactosylation, 152 pronounced differences between populations were also observed in the levels of 153 digalactosylated and sialylated glycans (Supplementary Table 3 ). Relations of age, country of 154 residence and sex with the total IgG glycans were evaluated to further investigate changes in 155 IgG glycan traits in different populations. Chronological age appeared to be a good predictor 156 of digalactosylation and agalactosylation variability (explaining 30% and 31% respectively), 157
while it was able to describe 20% of bisecting GlcNAc variability. Contrary to age, 158 participant's country of residence appeared to be the strongest predictor of core fucose levels 159 (P<6×10 -350 , n=5), explaining 57% of the variability in this glycan trait. It was also a good 160 predictor of monogalactosylation and sialylation variability. On the other hand, sex was able 161 to explain less than 1% of the variability of any glycan trait ( Supplementary Table 4 ). 162
Fc IgG glycan patterns in 14 countries 163
To validate observed diversity and unambiguously determine IgG N-glycosylation patterns in 164 different populations, while eliminating potential batch effects, we compared glycan features 165 derived from IgG subclass-specific Fc glycopeptides from 2,530 individuals (Supplementary  166   Table 5 , Supplementary Figure 3 ). This part of the study included 27 populations collected in 167 14 different countries ( Supplementary Table 6 ). Subclass-specific glycopeptides were 168 separated and accurate masses were measured for each glycoform. Calculated IgG Fc N-169 glycan derived traits displayed considerable variability between analysed populations. The Fc 170 N-glycome composition is known to differ from the total IgG N-glycome, as a result of Fab 171 N-glycome contribution to the total IgG glycome 29 . Again, the most prominent variation 172 appeared to be in level of IgG1 galactosylation (Figure 2 ), although expected decrease of this 173 glycan trait with the age of population was not observed. On the contrary, some populations 174 appeared to have lower galactosylation than expected for the given chronological age. median level of agalactosylation (45%), while the subjects from England exhibited the lowest 177 levels of this glycan trait (28%) on IgG1 subclass. The opposite effect was observed for 178 monogalactosylation levels -the subjects from Papua New Guinea had the lowest median 179 value of this glycan trait, while the highest levels were observed in the participants from 180
England. In a similar manner, participants from countries such as Germany and Italy had 181 higher monogalactosylation levels (comparable to subjects from England) than the ones from 182 countries such as Uganda, which were more similar to the subjects from Papua New Guinea 183
( Supplementary Table 7 ). 184
In the case of IgG2 and IgG4 subclasses, galactosylation levels displayed similar variation to 185 IgG1 subclass, although observed glycosylation patterns appeared to be subclass-specific, 186 especially in case of IgG4, which is the least abundant subclass in the human plasma 187
( Supplementary Tables 8 and 9) . 188
Age and county of residence can predict IgG Fc glycosylation 189
To determine the source of variation in IgG Fc glycan profiles, we analysed relationship of 190 glycan traits with sex, chronological age and country of residence. Here as well, 191 chronological age was a predictor of agalactosylation and digalactosylation variability ( Table  192 1). Interestingly, age was the best predictor of IgG2 digalactosylation. It was able to explain 193 28% of IgG2 agalactosylation variability compared to 22% in the case of IgG1. 194
Country of residence was the best predictor of IgG Fc monogalactosylation variability (Table  195 1). Namely, 38% of IgG1 Fc monogalactosylation variability was explained by the subject's 196 country of residence. Similar patterns were observed for IgG2 and IgG4 Fc glycosylation. 197
The same as in the case of total IgG glycans, sex was able to explain up to 1% of the IgG Fc Supplementary Table 13 ). As for the 209 subclasses IgG2 and IgG4, only monogalactosylation appeared to be significantly correlated 210 with the studied indicators. On the other hand, we did not observe any significant correlations 211 between any of the development indicators and sialylation or the incidence of bisecting 212
GlcNAc on any of the IgG subclasses. To determine the impact of the quality of health on IgG glycans, correlations between the two 225 were calculated. Population's health quality was expressed through overall health indices and 226 specific health indicators. Countries with lower development level, in general, had also lower 227 health-related indicators ( Supplementary Table 12 ). Majority of health-related indicators 228 appeared to be correlated with IgG monogalactosylation ( Supplementary Table 13 ). Supplementary Table 13 ).
Moreover, digalactosylation of IgG1 demonstrated five positive correlations with health-249 related development indicators, where skilled birth attendance and again, stunted growth, had 250 the strongest associations with this glycan trait ( Supplementary Table 13 ). P=0.01, n=14; Supplementary Table 13 ).
Discussion 259
IgG N-glycosylation varies between individuals within the same population as well as 260 between different populations 20,30 . In this study, we compared glycan profiles of the whole 261 glycosylation. Furthermore, a decrease in IgG galactosylation was observed in the premature 313 ageing syndromes 36 . Through modulation of inflammation, IgG galactosylation, or, more 314 precisely, agalactosylation is proposed to contribute to biological ageing in a process of 315 inflammaging 37 . Since the decrease in IgG galactosylation is a hallmark of increased 316 biological age, the proinflammatory IgG Fc glycosylation profile in individuals from 317 developing countries may imply accelerated biological ageing in these populations, resulting 318 in a shorter expected lifespan. 319
In summary, we revealed that at a community level, immunoglobulin G glycosylation 320 patterns vary between different countries. We also correlated changes in galactosylation with 321 participant's chronological age and development level of a country. Constant environmental 322 pressure on the immune system in developing countries maintains IgG constantly in under-323 galactosylated, proinflammatory state. As a consequence of this permanent low-degree IgG 324
Fc galactosylation, individuals from developing countries display premature populational 325 ageing and appear to be biologically "older" than residents of more developed countries. Table 6 ). For Kazak and English cohorts, we had two populations obtained 334 from different medical centres. Samples were randomized across 96-well plates (31 in total), 335 with 5 technical replicates of a standard sample and 1 blank, serving as a negative control. African populations predominant variant of the same peptide has the same amino acid 423 composition as IgG4 making the separation of IgG3 from other subclasses impossible using 424 given separation methods 45 . Therefore, IgG glycopeptides were separated into three 425 chromatographic peaks labeled IgG1, IgG2 and IgG4. Signals of interest were normalised to 426 the total area of each IgG subclass. 427
Materials and methods

Statistical analysis 428
Data analysis was performed using program R, version 3.0.1. with a ggplot2 package for 429 creation of visualisations. Derived glycan traits representing levels of galactosylation 430 (agalactosylation, monogalactosylation and digalactosylation), sialylation, core fucosylation 431 and incidence of bisecting GlcNAc were calculated from obtained data as described before 432
( Supplementary Tables 2 and 5) 43 . In short, traits were calculated as portion of glycans 433 containing common structural features in a total IgG glycome, or in a specific subclass of IgG 434 Fc glycopeptides. Core fucosylation was excluded from IgG Fc specific glycopeptide analysis 435 due to low data quality of non-fucosylated species. To remove experimental and batch 436 variation, batch correction was performed using a R ComBat package followed by log-437 transformation of glycan or glycopeptide data. Linear mixed model was used to analyse 438 correlations between glycan traits and the subject's country of residence. In the model, sex 439 and age were fixed effects, while the country of residence was used as a random effect. 440
Likelihood ratio test was used to determine significance of country of origin variability in 441 glycan trait variability. Pearson's correlation coefficient was used to express relationships 442 between country-specific development indicator and level of glycan trait in participants from 443 the same country. P values were adjusted for multiple testing using Bonferroni correction. 444
Data availability 445
The data that support the findings of this study are available from the corresponding author 446 upon reasonable request. 447 
